Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butorphanol dose-finding for prevention of sufentanil-induced cough during anesthesia induction
ChiCTR2100048774Phase 4Recruiting
- Sponsor
- Hunan Provincial People's Hospital
- Start
- Jan 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of butorphanol and sufentanil in cough (3 arms), sponsored by Hunan Provincial People's Hospital. Primary endpoint: Incidence of cough. Started Jan 2021; status: recruiting.
02
Drugs
butorphanolsufentanil
03
Conditions
cough
Beyond the preview
Go deeper on ChiCTR2100048774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048774.